Site içinde arama yapın

Swan Ben bir ses eklendi Health
2025-07-30 12:05:42 -

Ivermectin vs Paxlovid: COVID-25 Drug Comparison in 2025
As the world battles yet another variant-driven wave of coronavirus, dubbed COVID-25, attention has refocused on antiviral treatments. Among the top contenders for treatment are Ivermectin and Paxlovid—two drugs that have sparked heated debates in clinical, political, and public circles alike. With new FDA watchlist updates and emerging clinical results in...

0 Yorumlar 0 hisse senetleri 83 Views 0 önizleme

Please log in to like, share and comment!
Swan Ben bir ses eklendi Health
2025-07-10 09:46:28 -

Ivermectin & Generics: Will Patent Cliff Fuel Off-Label Use?
The U.S. pharmaceutical industry is bracing for one of the most influential shifts of 2025: ivermectin’s patent cliff. As this long-debated antiparasitic drug enters the generic realm, a whirlwind of regulatory, economic, and public health changes is expected. But among these changes, one question stands out: Will generic ivermectin’s wider availability lead to an increase...

0 Yorumlar 0 hisse senetleri 323 Views 0 önizleme

Please log in to like, share and comment!
Anya Rolfson bir ses eklendi Health
2025-05-31 12:26:56 -

New Hampshire Lawmakers Push for OTC Ivermectin Access
In a move stirring both praise and controversy, New Hampshire lawmakers are leading legislative efforts to legalize over-the-counter (OTC law) ivermectin, allowing access without a prescription. This initiative, spearheaded by Senate Bill 119, comes amid ongoing national debates about ivermectin's use, especially its off-label promotion during the COVID-19 pandemic. Supporters argue...

0 Yorumlar 0 hisse senetleri 839 Views 0 önizleme

Please log in to like, share and comment!
Anya Rolfson bir ses eklendi Health
2025-05-31 12:27:02 -

New Hampshire Lawmakers Push for OTC Ivermectin Access
In a move stirring both praise and controversy, New Hampshire lawmakers are leading legislative efforts to legalize over-the-counter (OTC law) ivermectin, allowing access without a prescription. This initiative, spearheaded by Senate Bill 119, comes amid ongoing national debates about ivermectin's use, especially its off-label promotion during the COVID-19 pandemic. Supporters argue...

0 Yorumlar 0 hisse senetleri 818 Views 0 önizleme

Please log in to like, share and comment!